PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1400988
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1400988
Asia Pacific Plasma Derived Therapy Market, By Product, By Application, By End-User, and By Country - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
REPORT HIGHLIGHT
Asia Pacific Plasma Derived Therapy Market size was valued at USD 130.5 Million in 2022, expanding at a CAGR of 11.5% from 2023 to 2030.
Life-saving medications called plasma-derived therapies are used to treat a variety of uncommon illnesses, including PIDs. They are created using plasma from donated human beings. Specialized biologic medications known as plasma-derived medicines are used to treat patients with dysfunctions and deficits in plasma proteins. Therapies produced from plasma replace lost or insufficient proteins, enabling people to live longer, healthier lives.
Plasma Derived Therapy Market- Market Dynamics
Increasing prevalence of uncommon diseases and demand for advanced technology in disease treatment are expected to propel market demand
The prevalence of rare diseases has significantly increased, necessitating the employment of specialized therapeutic interventions like plasma-derived therapy. The COVID-19 outbreak served as an illustration of a rare disease that was tried to be treated using plasma-derived therapy. The growing number of persons with genetic abnormalities has put future generations at risk because these individuals' conditions may worsen when they have children. As a result, the health care industry needs cutting-edge technologies in the therapeutic field. Furthermore, there is now a greater than ever need for cutting edge solutions to address genetic problems. However, the use of advanced treatment raises the total cost of treatment and so imposes an additional pressure on the people.
Plasma Derived Therapy Market- Key Insights
As per the analysis shared by our research analyst, the Asia Pacific market is estimated to grow annually at a CAGR of around 11.5% over the forecast period (2023-2030)
Based on Product segmentation, immunoglobulin segment was predicted to show maximum market share in the year 2022, increasing demand of the plasma derived component are fueling the market growth.
Based on Application segmentation, hemophilia was the leading market in 2022, due to high demand from disease related to blood clotting or bleeding.
Based on End-User segmentation, hospitals was the leading market in 2022, due to increasing demand for pesticides to improve the quality of plants and seeds.
On the basis of country, China held significant revenue share in 2022 mainly due to the growing healthcare sector and rising healthcare expenditure.
Plasma Derived Therapy Market- Segmentation Analysis:
The Asia Pacific Plasma Derived Therapy Market is segmented on the basis of Product, Application, End-User, and Region.
Plasma Derived Therapy Market- Competitive Landscape:
Recent Developments:
SCOPE OF THE REPORT
Table of Contents
1. Asia Pacific Plasma Derived Therapy Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Asia Pacific Plasma Derived Therapy Market Snippet by Product
- 2.1.2. Asia Pacific Plasma Derived Therapy Market Snippet by Application
- 2.1.3. Asia Pacific Plasma Derived Therapy Market Snippet by End-User
- 2.1.4. Asia Pacific Plasma Derived Therapy Market Snippet by Country
- 2.1.5. Asia Pacific Plasma Derived Therapy Market Snippet by Region
3. Plasma Derived Therapy Key Market Trends
4. Plasma Derived Therapy Industry Study
5. Asia Pacific Plasma Derived Therapy Market: COVID-19 Impact Analysis
6. Asia Pacific Plasma Derived Therapy Market Landscape
7. Asia Pacific Plasma Derived Therapy Market - By Product Type
8. Asia Pacific Plasma Derived Therapy Market - By Application
9. Asia Pacific Plasma Derived Therapy Market - By End-User
10. Asia Pacific Plasma Derived Therapy Market- By Country
11. Key Vendor Analysis- Asia Pacific Plasma Derived Therapy Industry
12. 360 Degree Analyst View
13. Appendix
